Showing results (1521-1530 of 2,300) with videos related to

Sort By:
Pageof 230
Molecular Cancer Therapeutics|September 21, 2006
A non-RGD-based integrin binding peptide (ATN-161) blocks breast cancer growth and metastasis in vivoParisa Khalili, Ani Arakelian, Gaoping Chen, et al.
British Journal of Haematology|April 27, 2012
Diagnosis and management of chronic graft-versus-host diseaseFiona L Dignan, Persis Amrolia, Andrew Clark, et al.
Plos One|October 17, 2018
Cofilin-actin rod formation in neuronal processes after brain ischemiaSeok Joon Won, Angela M Minnella, Long Wu, et al.
Bone Marrow Transplantation|May 23, 2020
Absence of damaging effects of stem cell donation in unrelated donors assessed by FISH and gene variance screeningE Nacheva, T Ahyee, J Addada, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 31, 2021
'For me, it didn't seem as drastic a step as being controlled by insulin': A qualitative investigation of expectations and experiences of non-insulin injectable therapy among adults with type 2 diabetesElizabeth Holmes-Truscott, Jasmine Schipp, Trisha Dunning, et al.
Biorxiv : the Preprint Server for Biology|June 11, 2026
A Novel Drug Candidate that Selectively Targets the Critical Androgen Receptor-ELK1 Growth Axis in Advanced and Drug-Resistant Prostate CancerClaire Soave, Lisa Polin, Charles Ducker, et al.
Diabetes Care|June 10, 2010
Mortality, all-cause and cardiovascular disease, over 15 years in multiethnic mauritius: impact of diabetes and intermediate forms of glucose toleranceDianna J Magliano, Stefan Söderberg, Paul Z Zimmet, et al.
Sleep|March 11, 1998
Do our methods lead to insomniacs' madness?: Daytime testing after laboratory and home-based polysomnographic studiesJ D Edinger, A I Fins, R J Sullivan, et al.
The Medical Journal of Australia|October 9, 2017
Testing for type 2 diabetes in Indigenous Australians: guideline recommendations and current practiceChristine L Paul, Paul Ishiguchi, Catherine A D'Este, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 24, 2020
The use of biotelemetry to explore disease progression markers in amyotrophic lateral sclerosisMadeline Kelly, Arseniy Lavrov, Luis Garcia-Gancedo, et al.
Pageof 230